BlackRock Advisors’s Dare Bioscience DARE Stock Holding History

BlackRock Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-824	Closed	-$104K	–	3719
2016 Q3	$104K	Sell	824 -466	-36%	-$104K	﹤0.01%	2998
2016 Q2	$328K	Sell	1,290 -195	-13%	-$62.4K	﹤0.01%	2351
2016 Q1	$483K	Sell	1,485 -11	-0.7%	-$3.1K	﹤0.01%	2088
2015 Q4	$503K	Sell	1,496 -14	-0.9%	-$5.81K	﹤0.01%	2072
2015 Q3	$663K	Hold	1,510	–	–	﹤0.01%	1985
2015 Q2	$833K	Buy	+1,510	New	+$1.04M	﹤0.01%	1796

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BlackRock Advisors's DARE Position: Q4 2016 in Review

BlackRock Advisors sold out of Dare Bioscience (DARE) in Q4 2016, closing a stake of 824 shares — an estimated $104K sold.

BlackRock Advisors first reported a position in DARE in Q2 2015 and held it in 6 quarters. The position peaked at $833K in Q2 2015. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2016.

BlackRock Advisors reported no remaining Dare Bioscience position as of Q4 2016 after selling out during the quarter.
BlackRock Advisors sold 824 Dare Bioscience shares in Q4 2016, an estimated $104K.
BlackRock Advisors first reported a position in Dare Bioscience in Q2 2015 and held it in 6 quarters.
BlackRock Advisors's Dare Bioscience position peaked at $833K in Q2 2015.
30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.